J 2019

Efficient and robust preparation of tyrosine phosphorylated intrinsically disordered proteins

BRÁZDA, Pavel, Ondrej ŠEDO, Karel KUBÍČEK and Richard ŠTEFL

Basic information

Original name

Efficient and robust preparation of tyrosine phosphorylated intrinsically disordered proteins

Authors

BRÁZDA, Pavel (203 Czech Republic, belonging to the institution), Ondrej ŠEDO (203 Czech Republic, belonging to the institution), Karel KUBÍČEK (203 Czech Republic, belonging to the institution) and Richard ŠTEFL (203 Czech Republic, guarantor, belonging to the institution)

Edition

BioTechniques, UNITED HOUSE, 2 ALBERT PL, LONDON N3 1QB, FUTURE SCI LTD, 2019, 0736-6205

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10608 Biochemistry and molecular biology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.541

RIV identification code

RIV/00216224:14740/19:00107820

Organization unit

Central European Institute of Technology

UT WoS

000475967900005

Keywords in English

C-terminal domain; co-expression; CTD; IDP; intrinsically disordered proteins; phosphorylation; purification; RNA polymerase II; TRANSCRIPTION TERMINATION; LARGEST SUBUNIT; CELL-CYCLE; KINASE; STRATEGIES; SEMISYNTHESIS

Tags

International impact, Reviewed
Změněno: 14/10/2024 13:09, Ing. Jana Kuchtová

Abstract

V originále

Intrinsically disordered proteins (IDPs) are subject to post-translational modifications. This allows the same polypeptide to undertake different interaction networks with different consequences, ranging from regulatory signalling networks to formation of membraneless organelles. We report a robust method for co-expression of modification enzyme and SUMO-tagged IDP with subsequent purification procedure allowing production of modified IDP. The robustness of our protocol is demonstrated on a challenging system, RNA polymerase II C-terminal domain (CM), that is a low-complexity repetitive region with multiple phosphorylation sites. In vitro phosphorylation approaches fail to yield multiple-site phosphorylated CTD, whereas our in vivo protocol allows to rapidly produce near homogeneous phosphorylated CTD at a low cost. These samples can be used in functional and structural studies.

Links

GA15-17670S, research and development project
Name: Molekulární podstata pro specifické rozpoznávání histonu H3K4me2 pomocí Set3 PHD domény
Investor: Czech Science Foundation
GA18-11397S, research and development project
Name: Molekulární achitektura komplexů ADAR - RNA
Investor: Czech Science Foundation
LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
649030, interní kód MU
Name: DECOR - Dynamic assembly and exchange of RNA polymerase II CTD factors (Acronym: DECOR)
Investor: European Union, DECOR, ERC (Excellent Science)
90043, large research infrastructures
Name: CIISB

Files attached